Brooklyn FI LLC Makes New $788,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Brooklyn FI LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 2,624 shares of the company’s stock, valued at approximately $788,000.

A number of other large investors have also bought and sold shares of the business. MML Investors Services LLC raised its holdings in shares of HCA Healthcare by 31.7% during the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after acquiring an additional 4,285 shares during the period. Meritage Group LP acquired a new position in shares of HCA Healthcare during the third quarter worth about $150,548,000. Galvin Gaustad & Stein LLC acquired a new stake in HCA Healthcare in the 4th quarter valued at approximately $18,044,000. Alpha DNA Investment Management LLC bought a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $869,000. Finally, NRI Wealth Management LC bought a new position in HCA Healthcare in the fourth quarter valued at $2,896,000. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on HCA shares. Barclays dropped their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Morgan Stanley decreased their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Royal Bank of Canada decreased their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. Finally, Truist Financial reduced their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Trading Up 1.3 %

Shares of HCA stock opened at $334.42 on Thursday. The stock has a market cap of $82.34 billion, a P/E ratio of 15.22, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock has a 50 day simple moving average of $320.53 and a 200 day simple moving average of $343.97. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the business earned $5.90 earnings per share. On average, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is 13.11%.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.